Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPBWR1 | P48145 | 18/20 | 0.66 |
| ▸ | GLP1R | P43220 | 2/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13363679 | 0.94 | NPBWR1 (0.69) | NPBWR1GLP1R | |
| SCHEMBL13363682 | 0.91 | GLP1R (0.69) | NPBWR1GLP1R | |
| SCHEMBL16508101 | 0.84 | IL23R (0.66) | NPBWR1GLP1R | |
| SCHEMBL16507895 | 0.84 | IL23R (0.63) | NPBWR1 | |
| SCHEMBL21191024 | 0.84 | NPBWR1 (0.61) | NPBWR1 | |
| SCHEMBL16507967 | 0.83 | IL23R (0.65) | NPBWR1GLP1R | |
| SCHEMBL30211346 | 0.83 | KISS1R (0.63) | NPBWR1 | |
| SCHEMBL16507822 | 0.83 | MMP2 (0.54) | GLP1R | |
| SCHEMBL21191025 | 0.83 | NPBWR1 (0.60) | NPBWR1 | |
| SCHEMBL26080241 | 0.82 | GLP1R (0.68) | NPBWR1GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110294738-A1 | PTHR1 RECEPTOR COMPOUNDS | ANTHOR THERAPEUTICS, INC. | 2011-12-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110294738-A1 | PTHR1 RECEPTOR COMPOUNDS | PTH1R, MC1R, CASR | NPBWR1 730/4885GLP1R 120/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.